Management of tremor by beta adrenergic blocking agents.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002526:Cerebellar Diseases / Q000150:complications; D006527:Hepatolenticular Degeneration / Q000150:complications; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications; D009103:Multiple Sclerosis / Q000150:complications; D010300:Parkinson Disease / Q000150:complications; D013375:Substance Withdrawal Syndrome / Q000150:complications; D014202:Tremor / Q000139:chemically induced / Q000145:classification / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists